Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | KIF11 | P52732 | 1/20 | 0.46 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.42 |
| ▸ | MMP3 | P08254 | 1/20 | 0.41 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.38 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.38 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | MGLL | Q99685 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL414397 | 0.86 | ALDH1A1 (0.50) | CYP2C9ALDH1A1KMT2AKDM4EPABPC1 | |
| SCHEMBL7729779 | 0.78 | CYP2C9 (0.50) | CYP2C9KIF11PTPN5MMP3BCL2L1 | |
| SCHEMBL7734271 | 0.77 | CYP2C9 (0.48) | CYP2C9KIF11PTPN5MMP3BCL2L1 | |
| SCHEMBL1758086 | 0.76 | ALDH1A1 (0.53) | CYP2C9ALDH1A1KMT2AKDM4EPABPC1 | |
| SCHEMBL9626191 | 0.76 | ALDH1A1 (0.46) | CYP2C9ALDH1A1KMT2AKDM4EPABPC1 | |
| SCHEMBL14076787 | 0.75 | KIF11 (0.47) | CYP2C9KIF11ALDH1A1 | |
| SCHEMBL410926 | 0.75 | KIF11 (0.45) | KIF11ALDH1A1KMT2A | |
| SCHEMBL25489530 | 0.74 | CYP2C9 (0.60) | CYP2C9KIF11PTPN5MMP3BCL2L1 | |
| SCHEMBL31589360 | 0.74 | CYP2C9 (0.60) | CYP2C9KIF11PTPN5MMP3BCL2L1 | |
| SCHEMBL4009331 | 0.74 | ALDH1A1 (0.49) | CYP2C9ALDH1A1KMT2AKDM4EPABPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2082890-B1 | Thermoplastic material comprising polychromic substances | DATALASE LTD (GB) | 2015-08-19 | — | — | EP | disclosed |
| US-8663902-B2 | Laser imaging | DATALASE LTD (GB) | 2014-03-04 | — | — | US | disclosed |
| US-8211620-B2 | Thermoplastic material comprising polychromic substances | THE PROCTER & GAMBLE COMPANY (US) | 2012-07-03 | — | — | US | disclosed |
| EP-2235591-B1 | POLYCHROMIC SUBSTANCES AND THEIR USE | DATALASE LTD (GB) | 2012-02-22 | — | — | EP | disclosed |
| US-20120021362-A1 | Laser Imaging | DATALASE LTD. (GB) | 2012-01-26 | — | — | US | disclosed |
| US-8083973-B2 | Polychromic substances and their use | DATALASE LTD. (GB) | 2011-12-27 | — | — | US | disclosed |
| US-20110109014-A1 | THERMOPLASTIC MATERIAL COMPRISING POLYCHROMIC SUBSTANCES | ROGERS NEIL JOHN | 2011-05-12 | — | — | US | disclosed |
| US-7897320-B2 | Thermoplastic material comprising polychromic substances | THE PROCTER & GAMBLE COMPANY (US) | 2011-03-01 | — | — | US | disclosed |
| US-20110017961-A1 | Polychromic Substances and Their Use | DATALASE LTD (GB) | 2011-01-27 | — | — | US | disclosed |
| US-20090191480-A1 | THERMOPLASTIC MATERIAL COMPRISING POLYCHROMIC SUBSTANCES | DATALASE LTD (GB) | 2009-07-30 | — | — | US | disclosed |
| EP-2082890-A1 | Thermoplastic material comprising polychromic substances | The Procter and Gamble Company (US) | 2009-07-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110017961-A1 | Polychromic Substances and Their Use | RXRG, RXRA, RXRB | CYP2C9 1628/4885KIF11 2551/4885PTPN5 2010/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.